Fred Telling serves as Executive at CELL THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Fred Telling has executed 91 insider transactions totaling $1.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 12, 2025 involved selling 210 shares valued at $197.
Fred Telling currently holds 34,538 shares of CELL THERAPEUTICS INC (CTIC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fred Telling has been a net buyer of CTIC stock. They have purchased $867.8K and sold $546.2K worth of shares.
Fred Telling's most recent insider trade was on Dec 12, 2025, when they sold 210 shares at $0.94 per share.
Get notified when new Form 4 filings are submitted
| $3.57 |
| Discretionary |
| Aug 8, 2023 | OGEN | $0 | Award | 25,000 | $N/A | Discretionary |
| Jun 17, 2022 | OGEN | $2.9K | Purchase | 10,084 | $0.29 | Discretionary |
| May 24, 2022 | OGEN | $22.8K | Purchase | 78,673 | $0.29 | Discretionary |
| May 23, 2022 | OGEN | $1.0K | Purchase | 3,500 | $0.29 | Discretionary |
| May 20, 2022 | OGEN | $18.4K | Purchase | 65,718 | $0.28 | Discretionary |
| May 19, 2022 | OGEN | $15.9K | Purchase | 56,806 | $0.28 | Discretionary |
| May 18, 2022 | OGEN | $4.0K | Purchase | 15,303 | $0.26 | Discretionary |
| Mar 31, 2022 | OGEN | $20.7K | Purchase | 59,053 | $0.35 | Discretionary |
| Mar 30, 2022 | OGEN | $44.9K | Purchase | 124,785 | $0.36 | Discretionary |
| Jun 29, 2021 | OGEN | $75.1K | Option Exercise | 156,540 | $0.48 | Discretionary |
| Nov 24, 2020 | OGEN | $37.0K | Purchase | 100,000 | $0.37 | Discretionary |
| Mar 25, 2019 | OGEN | $0 | Purchase | 100,000 | $N/A | Discretionary |
| Jul 17, 2018 | OGEN | $0 | Purchase | 100,000 | $N/A | Discretionary |
| Jun 22, 2018 | OGEN | $0 | Award | 4,000 | $N/A | Discretionary |
| Apr 29, 2017 | CTIC | $0 | Option Exercise | 34,736 | $N/A | Discretionary |
| Feb 9, 2017 | OGEN.BC | $0 | Award | 40,000 | $N/A | Discretionary |
| Jun 30, 2016 | OGEN.BC | $504.0K | Purchase | 969,180 | $0.52 | Discretionary |
| Apr 29, 2016 | CTIC | $0 | Option Exercise | 63,695 | $N/A | Discretionary |
| Feb 16, 2016 | OGEN | $0 | Award | 40,000 | $N/A | Discretionary |
| Dec 10, 2015 | CTIC | $0 | Disposition | 58,320 | $N/A | Discretionary |
| Mar 16, 2015 | OGEN | $0 | Award | 40,000 | $N/A | Discretionary |
| Nov 14, 2014 | OGEN | $4.1K | Purchase | 4,302 | $0.95 | Discretionary |
| Nov 14, 2014 | OGEN | $2.2K | Purchase | 2,400 | $0.91 | Discretionary |
| Nov 14, 2014 | OGEN | $91 | Purchase | 100 | $0.91 | Discretionary |
| Nov 14, 2014 | OGEN | $19.1K | Purchase | 20,098 | $0.95 | Discretionary |
| Nov 14, 2014 | OGEN | $95 | Purchase | 100 | $0.95 | Discretionary |
| May 30, 2014 | OGEN | $20.5K | Award | 10,000 | $2.05 | Discretionary |
| May 22, 2014 | CTIC | $0 | Award | 34,844 | $N/A | Discretionary |